The compounded medications our patients reach for most, formulated in our 503A facility and available by valid prescription
It was never approved to treat type 2 diabetes, for cosmetic or short-term weight loss purposes
368 Since GLP-1R is expressed in thyroid C cells and GLP-1 directly stimulates the secretion of calcitonin, which is a potent inhibitor of bone resorption in osteoclasts, GLP-1 may contribute to the nutrient-mediated reduction in bone resorption
We demonstrate that Bbs5 mutation disrupted energy homeostasis through impaired central nervous system processing of peripheral satiety cues potentially involving disruptions in adipose tissue and pancreatic function
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 118,99 per year only 9,92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF